Literature DB >> 20592274

A functional cross-talk between liver X receptor-α and constitutive androstane receptor links lipogenesis and xenobiotic responses.

Yonggong Zhai1, Tara Wada, Bin Zhang, Shaheen Khadem, Songrong Ren, Ramalinga Kuruba, Song Li, Wen Xie.   

Abstract

The liver X receptor (LXR) and constitutive androstane receptor (CAR) are two nuclear receptors postulated to have distinct functions. LXR is a sterol sensor that promotes lipogenesis, whereas CAR is a xenosensor that controls xenobiotic responses. Here, we show that LXRα and CAR are functionally related in vivo. Loss of CAR increased the expression of lipogenic LXR target genes, leading to increased hepatic triglyceride accumulation, whereas activation of CAR inhibited the expression of LXR target genes and LXR ligand-induced lipogenesis. On the other hand, a combined loss of LXR α and β increased the basal expression of xenobiotic CAR target genes, whereas activation of LXR inhibited the expression of CAR target genes and sensitized mice to xenobiotic toxicants. The mutual suppression between LXRα and CAR was also observed in cell culture and reporter gene assays. LXRα, like CAR, exhibited constitutive activity in the absence of an exogenously added ligand by recruiting nuclear receptor coactivators. Interestingly, although CAR competed with LXRα for coactivators, the constitutive activity and recruitment of coactivators was not required for CAR to suppress the activity of LXRα. In vivo chromatin immunoprecipitation assay showed that cotreatment of a CAR agonist compromised the LXR agonist responsive recruitment of LXRα to Srebp-1c, whereas an LXR agonist inhibited the CAR agonist-responsive recruitment of CAR to Cyp2b10. In conclusion, our results have revealed dual functions of LXRα and CAR in lipogenesis and xenobiotic responses, establishing a unique role of these two receptors in integrating xenobiotic and endobiotic homeostasis.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20592274      PMCID: PMC2981386          DOI: 10.1124/mol.110.064618

Source DB:  PubMed          Journal:  Mol Pharmacol        ISSN: 0026-895X            Impact factor:   4.436


  50 in total

1.  The repressed nuclear receptor CAR responds to phenobarbital in activating the human CYP2B6 gene.

Authors:  T Sueyoshi; T Kawamoto; I Zelko; P Honkakoski; M Negishi
Journal:  J Biol Chem       Date:  1999-03-05       Impact factor: 5.157

2.  Dual role of orphan nuclear receptor pregnane X receptor in bilirubin detoxification in mice.

Authors:  Simrat P S Saini; Ying Mu; Haibiao Gong; David Toma; Hirdesh Uppal; Songrong Ren; Song Li; Samuel M Poloyac; Wen Xie
Journal:  Hepatology       Date:  2005-03       Impact factor: 17.425

3.  LXR deficiency and cholesterol feeding affect the expression and phenobarbital-mediated induction of cytochromes P450 in mouse liver.

Authors:  Carmela Gnerre; Gertrud U Schuster; Adrian Roth; Christoph Handschin; Lisen Johansson; Renate Looser; Paolo Parini; Michael Podvinec; Kirsten Robertsson; Jan-Ake Gustafsson; Urs A Meyer
Journal:  J Lipid Res       Date:  2005-06-01       Impact factor: 5.922

4.  Nuclear receptors constitutive androstane receptor and pregnane X receptor ameliorate cholestatic liver injury.

Authors:  Catherine A M Stedman; Christopher Liddle; Sally A Coulter; Junichiro Sonoda; Jacqueline G A Alvarez; David D Moore; Ronald M Evans; Michael Downes
Journal:  Proc Natl Acad Sci U S A       Date:  2005-01-31       Impact factor: 11.205

5.  Role of the constitutive androstane receptor in xenobiotic-induced thyroid hormone metabolism.

Authors:  Mohammed Qatanani; Jun Zhang; David D Moore
Journal:  Endocrinology       Date:  2004-11-24       Impact factor: 4.736

6.  A pregnane X receptor agonist with unique species-dependent stereoselectivity and its implications in drug development.

Authors:  Ying Mu; Corey R J Stephenson; Christopher Kendall; Simrat P S Saini; David Toma; Songrong Ren; Hongbo Cai; Stephen C Strom; Billy W Day; Peter Wipf; Wen Xie
Journal:  Mol Pharmacol       Date:  2005-05-04       Impact factor: 4.436

7.  Nuclear receptors CAR and PXR cross talk with FOXO1 to regulate genes that encode drug-metabolizing and gluconeogenic enzymes.

Authors:  Susumu Kodama; Chika Koike; Masahiko Negishi; Yukio Yamamoto
Journal:  Mol Cell Biol       Date:  2004-09       Impact factor: 4.272

8.  Functional inhibitory cross-talk between constitutive androstane receptor and hepatic nuclear factor-4 in hepatic lipid/glucose metabolism is mediated by competition for binding to the DR1 motif and to the common coactivators, GRIP-1 and PGC-1alpha.

Authors:  Ji Miao; Sungsoon Fang; Yangjin Bae; Jongsook Kim Kemper
Journal:  J Biol Chem       Date:  2006-02-21       Impact factor: 5.157

9.  Androstane metabolites bind to and deactivate the nuclear receptor CAR-beta.

Authors:  B M Forman; I Tzameli; H S Choi; J Chen; D Simha; W Seol; R M Evans; D D Moore
Journal:  Nature       Date:  1998-10-08       Impact factor: 49.962

10.  A novel pregnane X receptor-mediated and sterol regulatory element-binding protein-independent lipogenic pathway.

Authors:  Jie Zhou; Yonggong Zhai; Ying Mu; Haibiao Gong; Hirdesh Uppal; David Toma; Songrong Ren; Ronald M Evans; Wen Xie
Journal:  J Biol Chem       Date:  2006-03-23       Impact factor: 5.157

View more
  19 in total

1.  The pregnane X receptor down-regulates organic cation transporter 1 (SLC22A1) in human hepatocytes by competing for ("squelching") SRC-1 coactivator.

Authors:  Lucie Hyrsova; Tomas Smutny; Alejandro Carazo; Stefan Moravcik; Jana Mandikova; Frantisek Trejtnar; Sabine Gerbal-Chaloin; Petr Pavek
Journal:  Br J Pharmacol       Date:  2016-04-08       Impact factor: 8.739

Review 2.  Xenobiotic metabolism, disposition, and regulation by receptors: from biochemical phenomenon to predictors of major toxicities.

Authors:  Curtis J Omiecinski; John P Vanden Heuvel; Gary H Perdew; Jeffrey M Peters
Journal:  Toxicol Sci       Date:  2010-11-08       Impact factor: 4.849

Review 3.  Drug metabolism alterations in nonalcoholic fatty liver disease.

Authors:  Matthew D Merrell; Nathan J Cherrington
Journal:  Drug Metab Rev       Date:  2011-05-25       Impact factor: 4.518

Review 4.  Pregnane X receptor and constitutive androstane receptor at the crossroads of drug metabolism and energy metabolism.

Authors:  Jie Gao; Wen Xie
Journal:  Drug Metab Dispos       Date:  2010-08-24       Impact factor: 3.922

5.  Non-additive hepatic gene expression elicited by 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) and 2,2',4,4',5,5'-hexachlorobiphenyl (PCB153) co-treatment in C57BL/6 mice.

Authors:  Anna K Kopec; Michelle L D'Souza; Bryan D Mets; Lyle D Burgoon; Sarah E Reese; Kellie J Archer; Dave Potter; Colleen Tashiro; Bonnie Sharratt; Jack R Harkema; Timothy R Zacharewski
Journal:  Toxicol Appl Pharmacol       Date:  2011-08-07       Impact factor: 4.219

Review 6.  Nuclear receptors and nonalcoholic fatty liver disease.

Authors:  Matthew C Cave; Heather B Clair; Josiah E Hardesty; K Cameron Falkner; Wenke Feng; Barbara J Clark; Jennifer Sidey; Hongxue Shi; Bashar A Aqel; Craig J McClain; Russell A Prough
Journal:  Biochim Biophys Acta       Date:  2016-03-04

7.  Activation of Constitutive Androstane Receptor Ameliorates Renal Ischemia-Reperfusion-Induced Kidney and Liver Injury.

Authors:  You-Jin Choi; Dong Zhou; Anne Caroline S Barbosa; Yongdong Niu; Xiudong Guan; Meishu Xu; Songrong Ren; Thomas D Nolin; Youhua Liu; Wen Xie
Journal:  Mol Pharmacol       Date:  2018-01-19       Impact factor: 4.436

8.  Polychlorinated Biphenyl-Xenobiotic Nuclear Receptor Interactions Regulate Energy Metabolism, Behavior, and Inflammation in Non-alcoholic-Steatohepatitis.

Authors:  Banrida Wahlang; Russell A Prough; K Cameron Falkner; Josiah E Hardesty; Ming Song; Heather B Clair; Barbara J Clark; J Christopher States; Gavin E Arteel; Matthew C Cave
Journal:  Toxicol Sci       Date:  2015-11-25       Impact factor: 4.849

Review 9.  Targeting xenobiotic receptors PXR and CAR for metabolic diseases.

Authors:  Jie Gao; Wen Xie
Journal:  Trends Pharmacol Sci       Date:  2012-08-10       Impact factor: 14.819

10.  Activation of the constitutive androstane receptor inhibits gluconeogenesis without affecting lipogenesis or fatty acid synthesis in human hepatocytes.

Authors:  Caitlin Lynch; Yongmei Pan; Linhao Li; Scott Heyward; Timothy Moeller; Peter W Swaan; Hongbing Wang
Journal:  Toxicol Appl Pharmacol       Date:  2014-05-27       Impact factor: 4.219

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.